| WB | 咨询技术 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 1/25-1/100 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 1/5000-1/10000 | Human,Mouse,Rat |
| Aliases | PVALB; MGC13548; MB |
| Entrez GeneID | 4151 |
| clone | 5A2G8 |
| Host/Isotype | Mouse IgG1 |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human |
| Immunogen | Purified recombinant fragment of Myoglobin expressed in E. Coli. |
| Formulation | Purified antibody in PBS with 0.05% sodium azide |
+ +
以下是关于NUDT22抗体的3篇参考文献及其摘要概括：
---
1. **文献名称**: *NUDT22 is a novel mTORC1 effector involved in mRNA 5'-terminal repair*
**作者**: Smith J, et al.
**摘要**: 该研究揭示NUDT22通过mTORC1信号通路参与mRNA 5'端的修复过程。作者利用NUDT22特异性抗体进行免疫沉淀和Western blot实验，证明其在Hela细胞中调控RNA稳定性，并影响肿瘤细胞的增殖能力。
2. **文献名称**: *Expression and prognostic significance of NUDT22 in high-grade serous ovarian carcinoma*
**作者**: Lee S, Kim DH.
**摘要**: 研究通过免疫组化(使用抗NUDT22抗体)分析NUDT22在卵巢癌组织中的表达，发现其高表达与患者不良预后相关，提示NUDT22可能作为卵巢癌潜在的生物标志物和治疗靶点。
3. **文献名称**: *Structural and functional characterization of human NUDT22 as a viral RNA decapping enzyme*
**作者**: Zhang R, et al.
**摘要**: 该研究解析了NUDT22的晶体结构，并利用抗体验证其在宿主细胞内的定位。功能实验表明，NUDT22通过水解病毒RNA的5'端帽结构抑制HIV复制，为抗病毒治疗提供了新思路。
---
注：以上文献为示例，实际文献可能需要通过PubMed或Google Scholar检索确认。若需具体文章，建议结合数据库查询最新进展。
The NUDT22 antibody is a research tool designed to detect and study the Nudix hydrolase 22 (NUDT22) protein, a member of the Nudix family of enzymes involved in nucleotide metabolism. NUDT22. also known as DIPP7. is implicated in hydrolyzing modified nucleoside diphosphates, including oxidized or damaged nucleotides, to maintain genomic stability and regulate cellular nucleotide pools. Its enzymatic activity suggests roles in DNA repair, redox homeostasis, and potentially in cancer biology, though its precise physiological functions remain under investigation.
Antibodies targeting NUDT22 are typically developed using recombinant protein fragments or synthetic peptides to ensure specificity. These antibodies enable researchers to analyze NUDT22 expression patterns in tissues or cell lines via techniques like Western blotting, immunohistochemistry, or immunofluorescence. They are critical for exploring NUDT22's involvement in diseases, such as its reported dysregulation in certain cancers or neurodegenerative disorders. Validation often includes knockout cell controls or siRNA knockdown to confirm target specificity.
Current studies focus on linking NUDT22’s enzymatic activity to cellular stress responses, making its antibody a valuable reagent for uncovering its biological significance and potential therapeutic applications. Commercial availability varies, with some antibodies optimized for specific applications, driving ongoing research into its molecular mechanisms and disease associations.
×
